172 related articles for article (PubMed ID: 2995050)
1. Evidence for a Na-K-ATPase-inhibitor in erythrocytes of patients with essential hypertension.
Walter U; Müller S
Eur J Clin Invest; 1985 Aug; 15(4):209-14. PubMed ID: 2995050
[TBL] [Abstract][Full Text] [Related]
2. [ATPase activity and sodium transport in erythrocytes of patients with essential hypertension (author's transl)].
Walter U
Klin Wochenschr; 1982 Jun; 60(12):607-16. PubMed ID: 6213810
[TBL] [Abstract][Full Text] [Related]
3. Na-K-ATPase in erythrocyte ghosts is not a marker for primary hypertension.
Wambach G; Helber A
Clin Exp Hypertens (1978); 1981; 3(4):663-73. PubMed ID: 6271508
[TBL] [Abstract][Full Text] [Related]
4. Cation fluxes and Na+-K+-activated ATPase activity in erythrocytes of patients with essential hypertension.
Swarts HG; Bonting SL; De Pont JJ; Stekhoven FM; Thien TA; Van't Laar A
Hypertension; 1981; 3(6):641-9. PubMed ID: 6271669
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte membrane sodium transport in patients with treated and untreated essential hypertension.
Cole CH
Circulation; 1983 Jul; 68(1):17-22. PubMed ID: 6303625
[TBL] [Abstract][Full Text] [Related]
6. Cation fluxes and (Na+ + K+)-activated ATPase activity in erythrocytes of patients with essential hypertension.
Swarts HG; Bonting SL; De Pont JJ; Schuurmans Stekhoven FM; Thien TA; Van't Laar A
Clin Exp Hypertens (1978); 1981; 3(4):831-49. PubMed ID: 6271511
[TBL] [Abstract][Full Text] [Related]
7. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
Canestrari F; Galli F; Gheller G; De Crescentini S; Biagiarelli B
Boll Soc Ital Biol Sper; 1991 Jul; 67(7):659-66. PubMed ID: 1667978
[TBL] [Abstract][Full Text] [Related]
8. Na-K-adenosine triphosphatase and cation content in the erythrocyte in essential hypertension.
Rahman M; Koh H; Primera MI; Del Greco F; Quintanilla AP
J Lab Clin Med; 1986 Apr; 107(4):337-41. PubMed ID: 3007645
[TBL] [Abstract][Full Text] [Related]
9. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
Maslova MN; Ogorodnikova LE; Titkov IuS
Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
[TBL] [Abstract][Full Text] [Related]
10. Effects of ouabain on membrane fluidity of erythrocytes in essential hypertension. An electron spin resonance study.
Tsuda K; Shima H; Kimura K; Nishio I; Masuyama Y
Am J Hypertens; 1991 Sep; 4(9):783-5. PubMed ID: 1657045
[TBL] [Abstract][Full Text] [Related]
11. Some properties of erythrocyte Na+-K+-ATPase in essential hypertension.
Kazennov AM; Maslova MN; Shalabodov AD; Bagrov JYu ; Gurevich VS
Clin Exp Hypertens A; 1987; 9(7):1221-32. PubMed ID: 3040305
[TBL] [Abstract][Full Text] [Related]
12. A circulating Na+-K+ATPase inhibitor, erythrocyte sodium transport and hypertension in patients with chronic renal failure.
Kariya K; Sano H; Yamanishi J; Saito K; Furuta Y; Fukuzaki H
Clin Exp Hypertens A; 1986; 8(2):167-83. PubMed ID: 2424645
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte Na+,K(+)-ATPase properties and adenylate energy charge in normotensives and in essential hypertensives.
Canestrari F; Galli F; Boschi S; Albertini MC; Gheller G; De Crescentini S; Bossú M
Clin Chim Acta; 1994 Jan; 224(2):167-79. PubMed ID: 8004787
[TBL] [Abstract][Full Text] [Related]
14. Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension.
Rodrigo R; Miranda-Merchak A; Valenzuela Grau R; Bachler JP; Vergara L
Clin Exp Hypertens; 2014; 36(1):17-26. PubMed ID: 23659494
[TBL] [Abstract][Full Text] [Related]
15. Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension.
Miyagi H; Higuchi M; Nakayama M; Moromizato H; Sakanashi M
Jpn J Pharmacol; 1991 Dec; 57(4):571-81. PubMed ID: 1666421
[TBL] [Abstract][Full Text] [Related]
16. Involvement of (Na+ + K+)-ATPase in binding and actions of palytoxin on human erythrocytes.
Böttinger H; Béress L; Habermann E
Biochim Biophys Acta; 1986 Sep; 861(1):165-76. PubMed ID: 2875735
[TBL] [Abstract][Full Text] [Related]
17. Relationship between (Na + K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects.
Rodrigo R; Bächler JP; Araya J; Prat H; Passalacqua W
Mol Cell Biochem; 2007 Sep; 303(1-2):73-81. PubMed ID: 17410406
[TBL] [Abstract][Full Text] [Related]
18. The effect of intracellular calcium on the sodium pump of human red cells.
Brown AM; Lew VL
J Physiol; 1983 Oct; 343():455-93. PubMed ID: 6315922
[TBL] [Abstract][Full Text] [Related]
19. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies on assay for Na-K ATPase in human blood cells. I. Erythrocyte Na-K ATPase assay in patients with thyroid dysfunction and in those with chronic renal failure].
Ogasawara H; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):329-39. PubMed ID: 2842203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
